Global market for Cardiac Defibrillators the market is forecast to exceed USD 16 billion by 2015. The market is primarily driven by the increasing incidence of cardiovascular diseases due to aging population and the increasing availability of emergency medical services worldover for the revival of sudden cardiac death victims. Cardiovascular disease (CVD) is one of the foremost causes for deaths globally. Sudden cardiac arrest survivors are prone to arrhythmic disorders, calling the need for defibrillation. If done within minutes of cardiac arrest, defibrillation can be life saving. Rising to the need, more number of defibrillators are being implanted in patients and deployed at public and private places. Cardiac defibrillators market is mainly governed by technological advancements and intense competition. The market is highly influenced by adoption of new technologies, demand for quality medical care, and addition of implantable defibrillators in the reimbursement scheme. Though growth in the implantable cardiac defibrillators market market remained slow in the recent past owing to product recalls and adverse media publicity, the outlook remains positive due to an under penetrated large patient population, as reported in a recent study published by Global Industry Analysts, Inc. Cardiac Defibrillators: A Global Strategic Business Report United States market for internal/implantable cardiac defibrillators is projected to reach USD 5.3 billion by 2010. In the external cardiac defibrillators market, growth is gaining momentum buoyed by growing public awareness of the benefits of Automated external defibrillators (AEDs) and increasing acceptance in the public access market. United States, Japan, and Europe account for about 85% of the world external cardiac defibrillators market by value sales. Europe, the second largest market is projected to reach USD 546 million by 2015. France, Germany, and United Kingdom account for about 50% of the market in Europe. Market for external cardiac defibrillators in Asia-Pacific is estimated at USD 74.5 million in 2008. India and China represent the fastest growing markets over the analysis period. A marked difference has been observed over the years with reference to size and weight. Some of the latest ICDs can also double up as pacemakers. ICD-CRT Cardiac resynchronization therapy (CRT), also known as CRT-D, is the major growth-driving factor in the field of cardiac rhythm management in the medical electronics market. As advancements become incremental in nature, differentiation of product attributes are expected to decline considerably. Key players profiled in the study include Biotronik GmbH & Co. KG, Boston Scientific Corporation, Cardiac Science Corporation, GE Healthcare Ltd, Medtronic, Inc., Physio-Control, Inc., Philips Healthcare, Nihon Kohden Corporation, St. Jude Medical, Inc, and Zoll Medical Corporation. More than 90% of the global cardiac defibrillators market is held by Medtronic, Boston Scientific, and St Jude Medical. The report titled “Cardiac Defibrillators: A Global Strategic Business Report” published by Global Industry Analysts, Inc., provides market estimates and projections for both Internal/Implantable Cardiac Defibrillators and External Defibrillators in terms of volume and dollar sales for the period 2000-2010. The study covers major market dynamics, trends, issues, and competition pertaining to the market. The report enumerates recent product launches, developments, mergers, acquisitions and other strategic industry activities. Analysis is presented for established and emerging markets including United States, Japan, Europe, France, Germany, United Kingdom, Italy, Asia-Pacific, Latin America, Middle East & Africa.